MRI Scan and Intra-labyrinthine Schwannoma

Brief Title

MRI Scan and Intra-labyrinthine Schwannoma

Official Title

INTEREST OF INTRAVENOUS INJECTION OF GADOLINIUM IN EXPLORATION INTRA-LABYRINTHINE SCHWANNOMA IN MRI 3 TESLAS

Brief Summary

      Evaluate the interest of gadolinium for the positive and topographic diagnosis of
      intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a
      sequence of fast imaging type employing steady state acquisition (FIESTA-C)
    



Study Type

Observational


Primary Outcome

Presence or absence of intra labyrinthine vestibular nerve tumor using T2 FIESTA alone


Condition

Schwannoma

Intervention

No intervention in this restrospective study


Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Other

Estimated Enrollment

30

Start Date

February 2, 2018

Completion Date

February 2019

Primary Completion Date

February 2019

Eligibility Criteria

        Inclusion Criteria:

          -  Age 18-80 years

          -  Have intra-labyrinthine schwannoma

          -  Have benefited from an MRI with gadolinium injection on the MRI 3T with interpretable
             sequences of good quality

          -  Subject giving their consent for their participation

          -  Subjects who benefited, between 2009 and 2016, from an MRI of the external auditory
             canals, with gadolinous product injection and on the 3 Tesla MRI, in which a diagnosis
             of intra labyrinthine schwannoma was made

        Exclusion Criteria:

        - Refusal to participate in the study
      

Gender

All

Ages

18 Years - 80 Years

Accepts Healthy Volunteers

No

Contacts

Francis VEILLON, MD, PhD, 33 3 88 12 78 65, [email protected]

Location Countries

France

Location Countries

France

Administrative Informations


NCT ID

NCT03580850

Organization ID

6809


Responsible Party

Sponsor

Study Sponsor

University Hospital, Strasbourg, France


Study Sponsor

Francis VEILLON, MD, PhD, Study Director, University Hospital, Strasbourg, France


Verification Date

February 2018